+499.5%
MRNA vs NDAQ
+4.3%
+495.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NDAQ | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.9% | -0.4% | -2.0% |
| 7D | +5.5% | -2.4% | +7.9% | +5.8% |
| 30D | +158.7% | +2.5% | +156.3% | +156.7% |
| 3M | +182.1% | +9.9% | +172.2% | +170.8% |
| 6M | +151.8% | +9.4% | +142.4% | +141.2% |
| YTD | +393.6% | +0.4% | +393.1% | +395.0% |
| 1Y | +499.5% | +4.0% | +495.4% | +484.9% |
| All | +499.5% | +4.3% | +495.2% | +484.9% |
Cumulative growth
Daily Returns
Daily percentage return beside NDAQ.
Daily Out/Under-Performance
Portfolio return minus NDAQ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NDAQ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NDAQ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling